PDSB
PDSB
US70465T1079
PDS Biotechnology Corporation
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
31.543.959 36.321.195
13.2%
Operating Income -31.543.959 -36.321.195
13.2%
Pretax Income -35.665.325 -38.479.553
7.3%
Net Income Common Stockholders -34.495.505 -37.610.384
8.3%
-- --
--
-- --
--
ende